Application 208558
- Type
- NDA
- Sponsor
- ASTRAZENECA PHARMS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LYNPARZA | OLAPARIB | TABLET;ORAL | 100MG | Yes | No |
| 002 | LYNPARZA | OLAPARIB | TABLET;ORAL | 150MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0668 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0679 | Lynparza | olaparib | AstraZeneca Pharmaceuticals LP | NDA | Current |